Treo Ventures, Llc
Venture capitalMinneapolis · Seed–Late Stage · 4 people tracked
Investment thesis
Treo Ventures targets medical device and digital health innovations addressing significant unmet clinical needs with the potential to substantially impact patient populations. The firm invests in companies spanning neuromodulation therapies, implantable devices, orthopedic solutions, and cardiovascular technologies. Their strategy emphasizes backing ventures with novel therapeutic approaches and experienced medical device teams capable of bringing technologies through clinical development to market.
Source: firm website, verified Jul 21, 2026.
Team · 4 people
from the firm's websitePreviously led Johnson & Johnson's venture arm JJDC before co-founding Treo Ventures.
Previously worked with Johnson & Johnson's venture arm JJDC and at Synergy Life Science Partners before co-founding Treo Ventures.
Joined Treo Ventures in 2020 as part of the investment team.
Listed as a contact for Treo Ventures with operations in Minneapolis and Dublin.
What they invest in
from 6 of 17 portfolio companiesMedical Devices ×5Healthtech ×4Biotech ×1Circular Economy ×1Deep Tech ×1Enterprise Software ×1
HQs:United States×5
Investments · 17 tracked
founders shown can be your intro pathDeveloping innovative neuromodulation therapy for large patient populations.
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery. The company aims to restore damaged joints for patients undergoing surgical intervention.
Medical DevicesLexington, US
Medical device company focused on treating chronic post-thrombotic venous occlusions and obstructions from deep vein thrombosis and chronic venous insufficiency.
Developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.
HealthtechMedical Devices
Neuspera develops an integrated sacral neuromodulation system for treating urinary urge incontinence, using a smart implanted neurostimulator paired with a wireless external battery. The device is designed for women with overactive bladder symptoms.
HealthtechMedical Devices
Developing implantable medical device technology with bioelectronic medicine approaches, initially targeting Urinary Urge Incontinence (UUI).
Developing novel device treatments for patients suffering from Restless Legs Syndrome (RLS).
Global medical device accelerator led by medical device veterans with locations in Ireland, Minneapolis, and Silicon Valley.
IT Asset Management Group provides IT asset disposition (ITAD), secure data destruction, and electronics recycling services for retired IT equipment. The company serves enterprises requiring certified data security, value recovery from used IT assets, and compliance with regulatory standards like NIST 800-88, HIPAA, and GDPR.
Circular EconomyEnterprise Software<UNKNOWN>
Clinical stage medical device company developing novel ultrasound-based treatment for inflammatory disorders.
SecondWave Systems develops a wearable ultrasound stimulation platform for noninvasive treatment of chronic and life-threatening diseases. The device uses ultrasound to modulate nerves and cells, with applications in treating inflammation, pain, and other conditions, and can be administered at home.
Deep TechHealthtechMedical Devices
Developing an innovative approach to treat migraine headaches; first spin-off from NuXcel.
Board seats · per SEC filings · 2
what is this? ⓘ$42.1M raise · filed Aug 2023 · via Mudit Jain
$17M raise · filed Jan 2021 · via Mudit Jain, Tracy Pappas
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Treo Ventures, Llc invest at?
- Treo Ventures, Llc invests at the Seed, Series A, Series B, Growth, Late Stage stages.
- What sectors does Treo Ventures, Llc focus on?
- Treo Ventures, Llc focuses on Digital Health, Healthtech, Medical Devices.
- Where is Treo Ventures, Llc located?
- Treo Ventures, Llc is headquartered in Minneapolis, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.